English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/167518
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids

AuthorsRodríguez Carrio, Javier; Salazar, Nuria ; Margolles Barros, Abelardo ; González, Sonia; Gueimonde Fernández, Miguel ; González de los Reyes-Gavilán, Clara ; Suárez, Ana
KeywordsFree fatty acids
Microbiota
Akkermansia
Short-chain fatty acids
Serum lipids
Subclinical metabolic alterations
Issue Date24-Jul-2017
PublisherFrontiers Media
CitationFrontiers in Immunology 8: 823 (2017)
AbstractA growing body of evidence highlights the relevance of free fatty acids (FFA) for human health, and their role in the cross talk between the metabolic status and immune system. Altered serum FFA profiles are related to several metabolic conditions, although the underlying mechanisms remain unclear. Recent studies have highlighted the link between gut microbiota and host metabolism. However, although most of the studies have focused on different clinical conditions, evidence on the role of these mediators in healthy populations is lacking. Therefore, we have addressed the analysis of the relationship among gut microbial populations, short-chain fatty acid (SCFA) production, FFA levels, and immune mediators (IFNγ, IL-6, and MCP-1) in 101 human adults from the general Spanish population. Levels of selected microbial groups, representing the major phylogenetic types present in the human intestinal microbiota, were determined by quantitative PCR. Our results showed that the intestinal abundance of Akkermansia was the main predictor of total FFA serum levels, displaying a negative association with total FFA and the pro-inflammatory cytokine IL-6. Similarly, an altered FFA profile, identified by cluster analysis, was related to imbalanced levels of Akkermansia and Lactobacillus as well as increased fecal SCFA, enhanced IL-6 serum levels, and higher prevalence of subclinical metabolic alterations. Although no differences in nutritional intakes were observed, divergent patterns in the associations between nutrient intakes with intestinal microbial populations and SCFA were denoted. Overall, these findings provide new insights on the gut microbiota–host lipid metabolism axis and its potential relevance for human health, where FFA and SCFA seem to play an important role.
Publisher version (URL)http://dx.doi.org/10.3389/fimmu.2017.00823
URIhttp://hdl.handle.net/10261/167518
DOI10.3389/fimmu.2017.00823
E-ISSN1664-3224
Appears in Collections:(IPLA) Artículos
Files in This Item:
File Description SizeFormat 
free_fatty_acids_rodriguez.pdf1,09 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.